Prognostic value of preoperative inflammatory markers in Chinese patients with breast cancer
about
Red cell distribution width and cancerThe neutrophil lymphocyte ratio is associated with breast cancer prognosis: an updated systematic review and meta-analysisPrognostic value of RDW in cancers: a systematic review and meta-analysisCombined Detection of Preoperative Neutrophil-to-Lymphocyte Ratio and CEA as an Independent Prognostic Factor in Nonmetastatic Patients Undergoing Colorectal Cancer Resection Is Superior to NLR or CEA AlonePrognostic value of neutrophil-to-lymphocyte ratio in breast cancer.Preoperative neutrophil-to-lymphocyte ratio is an independent prognostic marker in patients with laryngeal squamous cell carcinoma.The Peripheral Blood Neutrophil-To-Lymphocyte Ratio Is Superior to the Lymphocyte-To-Monocyte Ratio for Predicting the Long-Term Survival of Triple-Negative Breast Cancer Patients.Utility of pre-treatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic factors in breast cancerWhite blood cell and platelet indices as prognostic markers in patients with invasive ductal breast carcinoma.Preoperative neutrophil-lymphocyte ratio and fibrinogen level in patients distinguish between muscle-invasive bladder cancer and non-muscle-invasive bladder cancerUtility of Red Cell Distribution Width as a Prognostic Factor in Young Breast Cancer Patients.Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis.Preoperative red cell distribution width and neutrophil-to-lymphocyte ratio predict survival in patients with epithelial ovarian cancerAKT1low quiescent cancer cells persist after neoadjuvant chemotherapy in triple negative breast cancer.Usefulness of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in hormone-receptor-negative breast cancer.Elevated preoperative neutrophil-to-lymphocyte ratio predicts poor disease-free survival in Chinese women with breast cancer.The Clinical Importance of Measurement of Hematological Indices in the Breast Cancer Survivals: A Comparison Between Premenopausal and Postmenopausal WomenHigh Platelet-to-Lymphocyte Ratio Predicts Poor Prognosis and Clinicopathological Characteristics in Patients with Breast Cancer: A Meta-Analysis.Prognostic role of pretreatment neutrophil to lymphocyte ratio in breast cancer patients: A meta-analysis.Neutrophil/Lymphocyte and Platelet/Lymphocyte Ratios are Not Different among Breast Cancer SubtypesAssociation of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio with ER and PR in breast cancer patients and their changes after neoadjuvant chemotherapy.Prognostic role of the neutrophil-to-lymphocyte ratio (NLR) in patients with operable ampullary carcinoma.Prognostic Value of Combination of Pretreatment Red Cell Distribution Width and Neutrophil-to-Lymphocyte Ratio in Patients with Gastric Cancer.The value of neutrophil-to-lymphocyte ratio for response and prognostic effect of neoadjuvant chemotherapy in solid tumors: A systematic review and meta-analysis.Increased derived neutrophil-to-lymphocyte ratio and Breast Imaging-Reporting and Data System classification predict poor survival in patients with non-distant metastatic HER2+ breast cancer treated with neoadjuvant chemotherapyA prospective cohort examination of haematological parameters in relation to cancer death and incidence: the Busselton Health StudyPrognostic role of derived neutrophil-to-lymphocyte ratio in surgical triple-negative breast cancer
P2860
Q28066036-D1438E57-AB5A-4E7F-97F1-47259F457D3CQ28067745-BA74C2B0-D027-4F41-8EA4-A9F7DAF11F8AQ28069144-04CEA73B-C311-4B35-85C5-F528B4667AF1Q33823054-EC93EDE7-AB0E-4ACE-ACA9-785CEAFEFA42Q35790197-24ED76F3-39C6-47BF-AAD2-0135D4E52AD4Q35813764-0E13E8A3-562E-46FE-A65D-A43FA3874599Q35845330-5C5D4F4D-D43E-48B0-9A70-466706D47B09Q36286724-9AA36FBD-0DAC-4753-9C80-EF9199FA9A28Q37107759-AF7E3EFD-F5E9-4193-8AC2-B51378DBA504Q37170563-162FE6AA-4C4C-451F-A1F1-037A32E65617Q37206353-2A443BB8-B865-40CE-BC63-40862E0E46EAQ37566328-49319240-7193-4F64-AC98-0407DC340276Q37657622-EE9A18CA-AE56-43EF-A72E-9C7C589477C3Q38648335-1D75EC72-8866-4029-B422-82FA5F5EFE4CQ39479184-85A4B1EC-03C2-424C-A979-453C31CBC0F8Q40404266-575E09D1-1336-4AD7-B007-928CCFBE45C8Q42286673-C9AABFE7-E856-4DC6-8E71-99F1B4BF0086Q42730619-DB136057-4FAC-4FBB-AFE1-D49C3C3CB891Q45284997-C1459F51-A7B8-42CF-BA1D-12AE9543C404Q46843273-8708D76C-B252-4A43-AA70-CE3681C4A262Q47844340-B207BD21-8F9E-49AA-B5BB-164266C78760Q50047446-77F8D203-3F4D-4F5A-8642-A1BC4B60C041Q54987021-3E4A4E1B-1D57-458C-B12A-FD1C9CD83350Q55288835-CA1A5BFA-0310-4A91-999A-C1067D779129Q57070172-399E2F8E-DA11-4617-8305-15E4345BF6E6Q57161559-72E73165-2E92-4ED3-AFCC-984C90157308Q58694427-ECABDEBE-FF15-4ECF-92F8-A9E176A02EE4
P2860
Prognostic value of preoperative inflammatory markers in Chinese patients with breast cancer
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Prognostic value of preoperati ...... se patients with breast cancer
@ast
Prognostic value of preoperati ...... se patients with breast cancer
@en
Prognostic value of preoperati ...... se patients with breast cancer
@nl
type
label
Prognostic value of preoperati ...... se patients with breast cancer
@ast
Prognostic value of preoperati ...... se patients with breast cancer
@en
Prognostic value of preoperati ...... se patients with breast cancer
@nl
prefLabel
Prognostic value of preoperati ...... se patients with breast cancer
@ast
Prognostic value of preoperati ...... se patients with breast cancer
@en
Prognostic value of preoperati ...... se patients with breast cancer
@nl
P2093
P2860
P356
P1476
Prognostic value of preoperati ...... se patients with breast cancer
@en
P2093
Chengyong Du
Hailong Jin
Haiyan Wei
Shuqian Wang
Xiaojiao Liu
P2860
P304
P356
10.2147/OTT.S69657
P407
P577
2014-09-26T00:00:00Z